ITRM950143A0 - Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di composizioni farmaceutiche antipiretiche ed antinfiammatorie. - Google Patents

Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di composizioni farmaceutiche antipiretiche ed antinfiammatorie.

Info

Publication number
ITRM950143A0
ITRM950143A0 ITRM950143A ITRM950143A ITRM950143A0 IT RM950143 A0 ITRM950143 A0 IT RM950143A0 IT RM950143 A ITRM950143 A IT RM950143A IT RM950143 A ITRM950143 A IT RM950143A IT RM950143 A0 ITRM950143 A0 IT RM950143A0
Authority
IT
Italy
Prior art keywords
pharmaceutical compositions
aminotetralines
antipyretic
shock
substituted
Prior art date
Application number
ITRM950143A
Other languages
English (en)
Inventor
Piero Foresta
Vito Ruggiero
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM950143A0 publication Critical patent/ITRM950143A0/it
Priority to IT95RM000143A priority Critical patent/IT1278045B1/it
Priority to EP96102860A priority patent/EP0730861B1/en
Priority to AT96102860T priority patent/ATE195072T1/de
Priority to DE69609541T priority patent/DE69609541T2/de
Priority to DK96102860T priority patent/DK0730861T3/da
Priority to PT96102860T priority patent/PT730861E/pt
Priority to ES96102860T priority patent/ES2150034T3/es
Priority to US08/607,452 priority patent/US5591777A/en
Priority to TW085102443A priority patent/TW471967B/zh
Priority to CA002171081A priority patent/CA2171081A1/en
Priority to KR1019960005965A priority patent/KR100286141B1/ko
Priority to ZA961897A priority patent/ZA961897B/xx
Priority to JP8053075A priority patent/JPH08268884A/ja
Publication of ITRM950143A1 publication Critical patent/ITRM950143A1/it
Application granted granted Critical
Publication of IT1278045B1 publication Critical patent/IT1278045B1/it
Priority to GR20000402375T priority patent/GR3034688T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
IT95RM000143A 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di IT1278045B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT95RM000143A IT1278045B1 (it) 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di
ES96102860T ES2150034T3 (es) 1995-03-09 1996-02-26 Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
AT96102860T ATE195072T1 (de) 1995-03-09 1996-02-26 Verwendung von 6,7-substituierten-2- aminotetraline zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von septischem schock, und antipyretischer und antientzündlicher zusammensetzungen
DE69609541T DE69609541T2 (de) 1995-03-09 1996-02-26 Verwendung von 6,7-substituierten-2-Aminotetraline zur Herstellung von pharmazeutischen Zusammensetzungen zur Behandlung von septischem Schock, und antipyretischer und antientzündlicher Zusammensetzungen
DK96102860T DK0730861T3 (da) 1995-03-09 1996-02-26 Anvendelse af 6,7-substituerede 2-aminotetraliner til fremstilling af farmaceutiske præparater, der er nyttige til behandli
PT96102860T PT730861E (pt) 1995-03-09 1996-02-26 2-aminotetralinas 6, 7-substituidas para preparacao de composicoes farmaceuticas uteis para o tratamento do choque septico e composicoes farmaceuticas antipireticas e anti-inflamatorias
EP96102860A EP0730861B1 (en) 1995-03-09 1996-02-26 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
US08/607,452 US5591777A (en) 1995-03-09 1996-02-27 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
TW085102443A TW471967B (en) 1995-03-09 1996-02-29 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
CA002171081A CA2171081A1 (en) 1995-03-09 1996-03-05 Use of 6,7-substitute-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions
KR1019960005965A KR100286141B1 (ko) 1995-03-09 1996-03-07 6,7-치환-2-아미노테트랄린을 함유한 패혈성 쇼크 치료용 및 해열, 소염용 의약 조성물
ZA961897A ZA961897B (en) 1995-03-09 1996-03-08 6,7-substituted-2-aminotetralines and use thereof
JP8053075A JPH08268884A (ja) 1995-03-09 1996-03-11 敗血病性ショックの治療に有用な医薬組成物ならびに解熱および抗炎症医薬組成物を調製するための６，７−置換−２−アミノテトラリンの使用
GR20000402375T GR3034688T3 (en) 1995-03-09 2000-10-26 Use of 6,7-substituted-2-aminotetralines for preparing pharmaceutical compositions useful for the treatment of septic shock, and antipyretic and antiinflammatory pharmaceutical compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000143A IT1278045B1 (it) 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Publications (3)

Publication Number Publication Date
ITRM950143A0 true ITRM950143A0 (it) 1995-03-09
ITRM950143A1 ITRM950143A1 (it) 1996-09-09
IT1278045B1 IT1278045B1 (it) 1997-11-17

Family

ID=11403118

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000143A IT1278045B1 (it) 1995-03-09 1995-03-09 Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di

Country Status (14)

Country Link
US (1) US5591777A (it)
EP (1) EP0730861B1 (it)
JP (1) JPH08268884A (it)
KR (1) KR100286141B1 (it)
AT (1) ATE195072T1 (it)
CA (1) CA2171081A1 (it)
DE (1) DE69609541T2 (it)
DK (1) DK0730861T3 (it)
ES (1) ES2150034T3 (it)
GR (1) GR3034688T3 (it)
IT (1) IT1278045B1 (it)
PT (1) PT730861E (it)
TW (1) TW471967B (it)
ZA (1) ZA961897B (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1290910B1 (it) * 1997-02-03 1998-12-14 Sigma Tau Ind Farmaceuti 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
IT1294932B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
IT1294931B1 (it) * 1997-09-22 1999-04-23 Sigma Tau Ind Farmaceuti Derivati della 2-amminotetralina procedimento per la loro preparazione e composizioni farmaceutiche che li contengono, attive nella
US7125904B2 (en) 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199339B (it) * 1986-12-23 1988-12-30 Sigma Tau Ind Farmaceuti N-alchil derivati della 2-ammino-6,7-dimetossi tetralina,procedimenti per la loro preparazione e composizioni farmaceutiche ad attivita'an tiipertensiva che li contengono
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
IT1241988B (it) * 1990-06-15 1994-02-02 Sigma Tau Ind Farmaceuti 2- amminotetraline-6, 7-sostituite attive come immunomodulanti e composizioni farmaceutiche che le contengono

Also Published As

Publication number Publication date
ES2150034T3 (es) 2000-11-16
CA2171081A1 (en) 1996-09-10
GR3034688T3 (en) 2001-01-31
EP0730861B1 (en) 2000-08-02
DE69609541T2 (de) 2000-12-21
TW471967B (en) 2002-01-11
ATE195072T1 (de) 2000-08-15
EP0730861A1 (en) 1996-09-11
JPH08268884A (ja) 1996-10-15
PT730861E (pt) 2000-11-30
IT1278045B1 (it) 1997-11-17
ZA961897B (en) 1996-09-12
KR960033450A (ko) 1996-10-22
US5591777A (en) 1997-01-07
DK0730861T3 (da) 2000-10-09
ITRM950143A1 (it) 1996-09-09
KR100286141B1 (ko) 2001-04-16
DE69609541D1 (de) 2000-09-07

Similar Documents

Publication Publication Date Title
ITMI950529A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
BR9707501A (pt) Composto composição farmacêutica e uso do composto
ITMI950493A0 (it) Frazioni polifenoliche di te' loro uso e formulazioni che le contengono
NO911934L (no) Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner.
BR9707808A (pt) Composto composição farmacêutica e uso do composto
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
BR9612413A (pt) Composto uso do mesmo e composição farmacêutica
IT1297205B1 (it) Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
ITMI931680A0 (it) Procedimento per la preparazione di alcansolfonammidi
ITRM950143A0 (it) Uso di 2-amminotetraline-6,7-sostituite per la preparazione di composizioni farmaceutiche atte al trattamento dello shock, e di composizioni farmaceutiche antipiretiche ed antinfiammatorie.
ITFI950044A0 (it) Composti biciclici, loro preparazione ed uso in composizioni farmaceutiche
ITMI951417A0 (it) Composizioni farmaceutiche e procedimento per la loro preparazione
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
BR9509055A (pt) Imidazoloquinoxalinona uso da mesma e composiçao farmacêutica
IT1279064B1 (it) Catalizzatore di demetallizzazione per idrogenazione e preparazione dello stesso
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
ITBZ950045A0 (it) Gioiello e procedimento per la realizzazione dello stesso.
ITMI951733A0 (it) Procedimento per la preparazione di soluzioni di carbammati metallici n-alchil sostituiti e loro uso
IT1294932B1 (it) Uso di 2-amminotetraline-6,7 sostituite per la preparazione di composizioni farmaceutiche atte al trattamento di patologie
ITMI931897A0 (it) 1,3,4- benzotriazepin-554h)-one e procedimento per la loro preparazione
FI973631A (fi) 1,3-diolipohjaiset eetterit, menetelmä 1,3-diolipohjaisten eetterien valmistamiseksi sekä eetterien käyttö
IT1267205B1 (it) Procedimento per la preparazione di derivati della pirrolizina.
ITFI920146A1 (it) Proteine funzionalizzate e loro uso per la preparazione di traccianti coniugati
IT239670Y1 (it) Idro-contenitore per l'innalzamento provvisorio di argini.

Legal Events

Date Code Title Description
0001 Granted